Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8821896
Purified Plasmodium and vaccine composition
granted -
US 8821899
Method and process for the production of multi-coated recognitive and releasing systems
granted -
US 8822540
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted -
US 8822548
Compounds with activity at estrogen receptors
granted -
US 8822522
Dual-acting pyrazole antihypertensive agents
granted -
US 8822470
Substituted pyrido[2,3-b]pyrazines
granted -
US 8822218
Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
granted -
US 8821926
Tablet containing hardly soluble active ingredient
granted -
US 8822192
Human rotavirus vaccine strains and diagnostics
granted -
US 8821866
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted -
US 8822196
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 8822469
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
granted -
US 8822681
Azaindoles useful as inhibitors of janus kinases
granted -
US 8822685
2,4-pyrimidinediamine compounds and their uses
granted -
US 8822698
Aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the Met family
granted -
US 8822699
Heterocyclic compound and use thereof
granted -
US 8822700
Hepatitis C virus inhibitors
granted -
US 8815907
Quaternary ammonium compounds useful as muscarinic receptor antagonists
granted -
US 8815226
Protein-polymer-drug conjugates
granted -
US 8815227
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
granted -
US 8815511
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 8815240
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
granted -
US 8815246
Fc receptor binding proteins
granted -
US 8815558
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.